Navigation Links
A study to prevent sudden death in sports by means of genetic testing
Date:10/8/2009

The Foundation has donated a latest-generation gene sequencer to the hospital's Cardiovascular Research Unit for use in its research project "Genetic testing in cardiovascular pathologies linked to sudden cardiac death among young athletes". The device is already operating all day round in the Madrid hospital, from Monday to Friday, analyzing 16 samples per hour. It is equipped to detect the Brugada syndrome the cause of unexpected sudden cardiac death in apparently healthy hearts in just two hours, compared to the 25 hours needed by preceding technologies.

Although similar gene sequencers exist in Spain, this is the only device devoted exclusively to the study of alterations linked to sudden death in sports.

The donation was made in the frame of the ongoing agreement between the Hospital San Carlos Cardiology Service and the BBVA Foundation spanning basic and clinical research, healthcare and epidemiological analysis.

Seizures and pre-seizures among professional and amateur athletes

Spain, unlike other countries, has no reliable data on the incidence of sudden cardiac death in the general population, although the country has over 6 million registered athletes and over 12 million people engaging in some kind of sport. Estimates suggest that between 30 and 40 sportsmen or women die from this cause each year, though only deaths occurring during official competitions get covered in the media.

"Sudden death is the final consequence, but before that come seizures or pre-seizures, and it is here that we need to detect potential victims and bring them under clinical treatment", explains Antonio Lpez Farr, head of the Cardiovascular Research Unit within the hospital's Cardiology Service.

The research team will keep a record of all cases detected in the course of the study. For the moment, its scope is confined to the Madrid Region, where an agreement has been concluded with ambulance service SAMUR for a special code 33 to be activated in all cases of seizures involving an amateur or professional athlete.

This code indicates that the SAMUR team should transport the patient directly to Hospital Clnico. There, he or she will be treated in the Accident & Emergency Department and offered the choice of taking part in the study. Those who accept will be subjected to genetic tests using the sequencer installed in the Cardiovascular Research Unit in order to detect possible alterations associated with sudden death.

If some such alteration is found, the patient will be placed under the appropriate medical care, and also offered the opportunity to have his or her relatives tested to see if they suffer from the same pathology.

In its first weeks in operation, the sequencer has analyzed the genes of 85 athletes (65 men and 20 women). In each case a series of test were run depending on the possible condition. To date, 4,067 sequencings have been carried out along with 5,523 sequencing reactions.


'/>"/>

Contact: Silvia Churruca
comunicacion@fbbva.es
34-913-745-210
Fundacin BBVA
Source:Eurekalert

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
Breaking Medicine Technology: